Interacting Drugs |
Bicalutamide vs Ranolazine |
Security Level |
|
Mechanism |
Ranolazine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ranolazine. |
Management |
Limit the ranolazine adult dose to a maximum of 500 mg twice daily in patients concurrently receiving moderate CYP3A4 inhibitors (e.g., diltiazem, verapamil, erythromycin, etc.). |
Bicalutamide vs Ranolazine
Post Review about Bicalutamide vs Ranolazine Click here to cancel reply.
Other Interactions of Bicalutamide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.